From high mortgage rates to shortages that have spread coast to coast, New York Times reporter Emily Badger explains the roots -- and consequences of our country's broken housing system.
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.
- Gardiner Harris Science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
- Dr. Carolyn Hendricks A medical oncologist affiliated with Suburban Hospital in Bethesda.
- William Hubbard Former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Dr. Peter Bach Attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
Most Recent Shows
Fifty years after the Tuskegee study, Diane talks to Harvard's Evelynn Hammonds about the intersection of race and medicine in the United States, and the lessons from history that can help us understand health inequities today.
Pills, the right to travel and fetal personhood laws -- Diane talks to Temple University Law School's Rachel Rebouché about what's next in the fight over abortion in the U.S.
What's happened to groups like the Oath Keepers and Proud Boys post-January 6, and the ongoing threat of far-right extremism in this country. Diane talks to Sam Jackson, author of "Oath Keepers: Patriotism and the Edge of Violence in a Right-Wing Antigovernment Group"